Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2000; 84(01): 138-139
DOI: 10.1055/s-0037-1613983
DOI: 10.1055/s-0037-1613983
Letters to the Editor
Activated Protein C (APC) Resistance: Considerations about the Importance of Using the Original and Modified Methods in Thrombophilic Disease
This work was partially supported by Fundaciόn “Alberto J. Roemmers” and by Fundaciόn “René Baron”, Buenos Aires, Argentina.
Further Information
Publication History
Received
02 February 2000
Accepted after revision
29 February 2000
Publication Date:
10 December 2017 (online)
-
References
- 1 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-8.
- 2 Bertina RM. Molecular risk factors for thrombosis. Thromb Haemost 1999; 82: 601-9.
- 3 Dahlbäck B. Activated protein C resistance and thrombosis: Molecular mechanisms of hypercoagulable state due to FVR506Q mutation. Semin Thromb Hemost 1999; 25: 273-89.
- 4 de Visser MCH, Rosendaal FR, Bertina RM. A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis. Blood 1999; 93: 1271-6.
- 5 Kiechl S, Muigg A, Santer P, Mitterer M, Egger G, Oberhollenzer M, Oberhollenzer F, Mayr A, Gasperi A, Poewe W, Willeit J. Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease. Circulation 1999; 99: 614-9.
- 6 Jorquera JI, Montoro JM, Fernández MA, Aznar JA, Aznar J. Modified test for activated protein C resistance. Lancet 1994; 344: 1162-3.